[Conclusions. Position of rilpivirine in the management of infection by the human immunodeficiency virus]
- PMID: 24252533
- DOI: 10.1016/S0213-005X(13)70142-3
[Conclusions. Position of rilpivirine in the management of infection by the human immunodeficiency virus]
Similar articles
-
[Introduction. Rilpivirine].Enferm Infecc Microbiol Clin. 2013 Jun;31 Suppl 2:1. doi: 10.1016/S0213-005X(13)70135-6. Enferm Infecc Microbiol Clin. 2013. PMID: 24252526 Spanish. No abstract available.
-
[Resistance profile of rilpivirine].Enferm Infecc Microbiol Clin. 2013 Jun;31 Suppl 2:36-43. doi: 10.1016/S0213-005X(13)70141-1. Enferm Infecc Microbiol Clin. 2013. PMID: 24252532 Review. Spanish.
-
Rilpivirine: a step forward in tailored HIV treatment.Lancet. 2011 Jul 16;378(9787):201-3. doi: 10.1016/S0140-6736(11)60992-6. Lancet. 2011. PMID: 21763920 No abstract available.
-
Rilpivirine (Edurant)--a new drug for HIV infection.Med Lett Drugs Ther. 2011 Aug 22;53(1371):67-8. Med Lett Drugs Ther. 2011. PMID: 21860365 No abstract available.
-
[Mechanism of action and pharmacokinetics of rilpivirine].Enferm Infecc Microbiol Clin. 2013 Jun;31 Suppl 2:2-5. doi: 10.1016/S0213-005X(13)70136-8. Enferm Infecc Microbiol Clin. 2013. PMID: 24252527 Review. Spanish.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical